Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Century Therapeutics Inc (IPSC)

Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 140,272
  • Shares Outstanding, K 84,501
  • Annual Sales, $ 2,240 K
  • Annual Income, $ -136,670 K
  • 60-Month Beta 1.36
  • Price/Sales 60.27
  • Price/Cash Flow N/A
  • Price/Book 0.61
Trade IPSC with:

Options Overview Details

View History
  • Implied Volatility 242.79% ( +242.79%)
  • Historical Volatility 83.77%
  • IV Percentile 81%
  • IV Rank 23.87%
  • IV High 968.02% on 07/23/24
  • IV Low 15.43% on 05/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 21
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 412
  • Open Int (30-Day) 336

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.46
  • Number of Estimates 3
  • High Estimate -0.41
  • Low Estimate -0.51
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +16.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4200 +16.20%
on 09/06/24
2.0500 -19.51%
on 08/26/24
+0.0400 (+2.48%)
since 08/16/24
3-Month
1.4200 +16.20%
on 09/06/24
3.2900 -49.85%
on 07/16/24
-1.3200 (-44.44%)
since 06/18/24
52-Week
1.2800 +28.91%
on 11/13/23
5.5100 -70.05%
on 03/08/24
-0.5900 (-26.34%)
since 09/18/23

Most Recent Stories

More News
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?

Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate.

YMAB : 13.57 (-5.17%)
IPSC : 1.6500 (-0.60%)
EDIT : 3.88 (+0.52%)
FATE : 3.88 (-3.00%)
JNJ : 166.15 (-0.55%)
ELEV : 0.5942 (-1.54%)
Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

- Following the recent submission of the IND application for CNTY-101 and pending FDA clearance, the Phase 1 ELiPSE-1 trial in relapsed/refractory lymphoma...

IPSC : 1.6500 (-0.60%)
Century Therapeutics Announces Its Addition to the Russell Microcap® Index

PHILADELPHIA, June 24, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 1.6500 (-0.60%)
Century Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium

PHILADELPHIA, June 21, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 1.6500 (-0.60%)
Century Therapeutics to Host Virtual Research and Development Day on June 13, 2022

PHILADELPHIA, June 06, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 1.6500 (-0.60%)
Century Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates

- Phase 1 ELiPSE-1 trial of CNTY-101 in relapsed/refractory lymphoma expected to commence in the second half of 2022 following IND submission in mid 2022- ...

IPSC : 1.6500 (-0.60%)
Century Therapeutics to Present at Upcoming Investor Conferences

PHILADELPHIA, May 03, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 1.6500 (-0.60%)
Century Therapeutics to Present at the ASGCT 25th Annual Meeting

PHILADELPHIA, May 02, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 1.6500 (-0.60%)
Century Therapeutics to Present at the Chardan Genetic Medicines and Cell Therapy Manufacturing Summit

PHILADELPHIA, April 18, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 1.6500 (-0.60%)
Century Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

PHILADELPHIA, April 06, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 1.6500 (-0.60%)

Business Summary

Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

See More

Key Turning Points

3rd Resistance Point 1.8533
2nd Resistance Point 1.7967
1st Resistance Point 1.7233
Last Price 1.6500
1st Support Level 1.5933
2nd Support Level 1.5367
3rd Support Level 1.4633

See More

52-Week High 5.5100
Fibonacci 61.8% 3.8941
Fibonacci 50% 3.3950
Fibonacci 38.2% 2.8959
Last Price 1.6500
52-Week Low 1.2800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar